VBIV - VBI Vaccines Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue38.61-957.835-1,568.041
Cost of Revenue---
Gross Profit38.61-957.835-1,568.041
Operating Expenses
Research Development7,074.8023,176.991,435.042
Selling General and Administrative6,476.7689,985.9462,164.519
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-13,512.96-14,120.771-5,167.602
Income from Continuing Operations
Total Other Income/Expenses Net-382.777-287.038-284.267
Earnings Before Interest and Taxes-13,538.387-13,449.974-3,883.828
Interest Expense357.35957.8351,568.041
Income Before Tax-13,895.737-14,407.809-5,451.869
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-13,895.737-14,407.809-5,451.869
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-13,895.737-14,407.809-5,451.869
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-13,895.737-14,407.809-5,451.869